Natural polymorphisms of integrase among HIV type 1-infected South African patients

AIDS Research and Human Retroviruses

Volumn 26, Issue 4, 2010, Pages 489-493

  Fish, Muhammad Q ^a   Hewer, Raymond ^b   Wallis, Carole L ^a   Venter, Willem D F ^a   Stevens, Wendy S ^a   Papathanasopoulos, Maria A ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b MINTEK   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ELVITEGRAVIR; INTEGRASE; RALTEGRAVIR;

ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME POLYMORPHISM; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SOUTH AFRICA; VIRUS CLASSIFICATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; DRUG RESISTANCE, MULTIPLE, VIRAL; GENETIC VARIATION; HIV INFECTIONS; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRROLIDINONES; QUINOLONES; RNA, VIRAL; SOUTH AFRICA;

EID: 77951857883     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0249     Document Type: Article

References (18)

1. Engelman A, Mizuuchi K, and Craigie R: HIV-1 DNA integration: Mechanisms of viral DNA cleavage and DNA strand transfer. Cell 1991;67:1211-1221.
2. Van Maele B, Busschots K, Vandekerckhove L, Christ F, and Debyser Z: Cellular co-factors of HIV-1 integration. Trends Biochem Sci 2006;31:98-105.
3. LaFemina RL, Schneider CL, Robbins HL, et al.: Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol 1992;66:7414-7419.
4. Sakai H, Kawamura M, Sakuragi J, et al.: Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J Virol 1993;67:1169-1174.
5. Miller MD, Farnet CM, and Bushman FD: Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition. J Virol 1997;71:5382-5390.
6. Van Maele B and Debyser Z: HIV-1 integration: An interplay between HIV-1 integrase, cellular and viral proteins. AIDS Rev 2005;7:26-43.
7. Yoder KE and Bushman FD: Repair of gaps in retroviral DNA integration intermediates. J Virol 2000;74:11191-11200.
8. Pommier Y, Johnson AA, and Marchand C: Integrase inhibitors to treat HIV/AIDS. Nat Rev Drug Discov 2005;4:236-248.
9. Van Laethem K, Schrooten Y, Covens K, et al.: A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes. J Virol Methods 2008;153: 176-181.
10. Van Baelen K, Rondelez E, van Eygen V, et al.: A combined genotypic and phenotypic human immunodeficiency virus type 1 recombinant virus assay for the reverse transcriptase and integrase genes. J Virol Methods 2009;161:231-239.
11. Eshleman SH, Hudelson SE, Smith P, et al.: Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. AIDS Res Hum Retroviruses 2009;25:343-345.
12. Connell BJ, Michler K, Capovilla A, et al.: Emergence of X4 usage amongst HIV-1 subtype C: Evidence for an evolving epidemic in South Africa. AIDS 2008;22:896-899.
13. Rousseau CM, Birditt BA, McKaya AR, et al.: Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. J Virol Methods 2006;136:118-125.
14. Rhee SY, Liu TF. Kiuchi M, et al.: Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors. Retrovirology 2008;5:74.
15. Hunt GM, Papathanasopolous MA, Gray GE, and Tiemessen CT: Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates. Virus Genes 2003;26:49-56.
16. Tzitzivacos DB, Tiemessen CT, Stevens WS, and Papathanasopoulos MA: Viral genetic determinants of nonprogressive HIV-1 subtype C infection in antiretroviral drug naïve children. AIDS Res Hum Retroviruses 2009;25:1141-1148.
17. Passaes CB, Guimaraes ML, Fernandez SLC, et al.: Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil. J Acquir Immune Defic Syndr 2009;51:7-12.
18. Ceccherini-Silberstein F, Malet I, Fabeni L, et al.: Specific mutations related to resistance to HIV-1 integrase inhibitors are associated with reverse transcriptase mutations in HAART-treated patients. Antivir Ther 2007;12:S6.